1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Sri Lanka Pharmaceuticals and Healthcare Report Q1 2016

Sri Lanka Pharmaceuticals and Healthcare Report Q1 2016

  • January 2016
  • -
  • Business Monitor International
  • -
  • 72 pages

Includes 3 FREE quarterly updates

BMI View: Sales of medicines in Sri Lanka will see reasonable growth ahead Commercial opportunitiesare curtailed by the Sri Lanka's under-developed healthcare system and preference for generic drugsMultinational drugmaker investments, which could catalyse the sector's growth, will be impaired by thedominant position of state-linked firms and the depreciation of the Sri Lankan rupee

Headline Expenditure Projections
- Pharmaceuticals: LKR751bn (USD575mn) in 2014 to LKR82bn (USD771mn) in 2015 Forecastsremain flat compared with the previous quarter with a downgrade in US dollar terms
- Healthcare: LKR2825bn (USD22bn) in 2014 to LKR4240bn (USD29bn) in 2015 Forecasts areslightly up compared with the previous quarter with a downgrade in US dollar terms

Table Of Contents

Sri Lanka Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Sri Lanka 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Sri Lanka 2011-2019) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Sri Lanka 2011-2019) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Sri Lanka 2011-2019) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Sri Lanka 2011-2019) 16
Prescription Drug Market Forecast 16
Pharmaceutical Trade Forecast 18
Table: Pharmaceutical Trade Data And Forecasts (Sri Lanka 2013-2019) 20
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Sri Lanka 2013-2019) 20
Industry Risk Reward Indices 21
Asia Pacific Risk/Reward Index 21
Sri Lanka - Risk/Reward Index 28
Rewards 28
Risks 28
Regulatory Review 29
Intellectual Property Issues 32
Pricing And Reimbursement Regimes 33
Supply Chain 34
Market Overview 36
Healthcare Sector 36
Clinical Trials 40
Epidemiology 41
Competitive Landscape 47
Pharmaceutical Industry 47
Table: Multinational Market Activity 48
Pharmaceutical Distribution And Retail 49
Company Profile 51
GlaxoSmithKline 51
Hemas Holdings 54
State Pharmaceuticals Corporation (SPC) 57
Demographic Forecast 61
Demographic Outlook 61
Table: Population Headline Indicators (Sri Lanka 1990-2025) 62
Table: Key Population Ratios (Sri Lanka 1990-2025) 62
Table: Urban/Rural Population and Life Expectancy (Sri Lanka 1990-2025) 63
Table: Population By Age Group (Sri Lanka 1990-2025) 63
Table: Population By Age Group % (Sri Lanka 1990-2025) 64
Glossary 66
Methodology 68
Pharmaceutical Expenditure Forecast Model 68
Healthcare Expenditure Forecast Model 68
Notes On Methodology 69
Risk/Reward Index Methodology 70
Index Overview 71
Table: Pharmaceutical Risk/Reward Index Indicators 71
Indicator Weightings 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.